questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Structures de chromosome
Chromatides
Chromatides : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chromatides : Questions médicales les plus fréquentes",
"headline": "Chromatides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chromatides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chromatides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures de chromosome",
"url": "https://questionsmedicales.fr/mesh/D022004",
"about": {
"@type": "MedicalCondition",
"name": "Structures de chromosome",
"code": {
"@type": "MedicalCode",
"code": "D022004",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.160"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chromatides",
"alternateName": "Chromatids",
"code": {
"@type": "MedicalCode",
"code": "D002842",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Job de Lange",
"url": "https://questionsmedicales.fr/author/Job%20de%20Lange",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Genetics, Section Oncogenetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands j.delange1@amsterdamumc.nl."
}
},
{
"@type": "Person",
"name": "Daniel W Gerlich",
"url": "https://questionsmedicales.fr/author/Daniel%20W%20Gerlich",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter, Vienna, Austria. daniel.gerlich@imba.oeaw.ac.at."
}
},
{
"@type": "Person",
"name": "Martin A Rooimans",
"url": "https://questionsmedicales.fr/author/Martin%20A%20Rooimans",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Genetics, Section Oncogenetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands."
}
},
{
"@type": "Person",
"name": "Janne J M van Schie",
"url": "https://questionsmedicales.fr/author/Janne%20J%20M%20van%20Schie",
"affiliation": {
"@type": "Organization",
"name": "Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Jesper A Balk",
"url": "https://questionsmedicales.fr/author/Jesper%20A%20Balk",
"affiliation": {
"@type": "Organization",
"name": "Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "How Should Biocontainment Balance Infection Control With Practice Sustainability?",
"datePublished": "2022-10-01",
"url": "https://questionsmedicales.fr/article/36215186",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/amajethics.2022.944"
}
},
{
"@type": "ScholarlyArticle",
"name": "Challenges to infection control in early communication intervention: A scoping review.",
"datePublished": "2022-08-03",
"url": "https://questionsmedicales.fr/article/36073070",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/sajcd.v69i2.911"
}
},
{
"@type": "ScholarlyArticle",
"name": "Infection prevention and control staffing and programs in Middle Eastern Countries.",
"datePublished": "2022-05-30",
"url": "https://questionsmedicales.fr/article/35656962",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3855/jidc.15504"
}
},
{
"@type": "ScholarlyArticle",
"name": "Compliance and adherence to hand hygiene practices for effective infection control.",
"datePublished": "2024-04-01",
"url": "https://questionsmedicales.fr/article/38822468",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2166/wh.2024.384"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mechanical complications and infection control comparison of custom-made and prefabricated articular hip spacers in the treatment of periprosthetic infection.",
"datePublished": "2023-08-21",
"url": "https://questionsmedicales.fr/article/37750259",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.52312/jdrs.2023.1155"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Structures de chromosome",
"item": "https://questionsmedicales.fr/mesh/D022004"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chromatides",
"item": "https://questionsmedicales.fr/mesh/D002842"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chromatides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chromatides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chromatides",
"description": "Comment identifier les chromatides lors de la mitose ?\nQuels tests révèlent des anomalies des chromatides ?\nLes chromatides peuvent-elles être analysées par PCR ?\nQuel rôle joue l'immunofluorescence dans l'étude des chromatides ?\nPeut-on observer les chromatides en microscopie électronique ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Infection+Control&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chromatides",
"description": "Quels symptômes indiquent des anomalies chromosomiques ?\nLes anomalies des chromatides causent-elles des maladies ?\nComment les anomalies des chromatides affectent-elles la santé ?\nLes symptômes des troubles chromosomiques sont-ils visibles à la naissance ?\nLes troubles des chromatides peuvent-ils affecter la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Infection+Control&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chromatides",
"description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue l'alimentation dans la prévention des anomalies chromosomiques ?\nLes tests génétiques peuvent-ils aider à prévenir des anomalies ?\nLa vaccination peut-elle prévenir des anomalies chromosomiques ?\nLe suivi médical régulier aide-t-il à prévenir les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Infection+Control&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chromatides",
"description": "Quels traitements existent pour les anomalies chromosomiques ?\nLa chimiothérapie est-elle utilisée pour traiter des anomalies des chromatides ?\nLes traitements sont-ils disponibles pour le syndrome de Turner ?\nPeut-on corriger les anomalies chromosomiques par chirurgie ?\nLes thérapies géniques sont-elles efficaces contre les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Infection+Control&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chromatides",
"description": "Quelles complications peuvent résulter d'anomalies chromosomiques ?\nLes anomalies des chromatides peuvent-elles entraîner des complications à long terme ?\nComment les anomalies chromosomiques affectent-elles la santé mentale ?\nLes complications des anomalies chromosomiques sont-elles réversibles ?\nLes anomalies chromosomiques augmentent-elles le risque de maladies auto-immunes ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Infection+Control&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chromatides",
"description": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?\nLes infections pendant la grossesse augmentent-elles les risques chromosomiques ?\nL'exposition aux radiations influence-t-elle les anomalies chromosomiques ?\nLe tabagisme maternel est-il un facteur de risque ?\nLes facteurs génétiques jouent-ils un rôle dans les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Infection+Control&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les chromatides lors de la mitose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chromatides sont visibles sous un microscope lors de la métaphase de la mitose."
}
},
{
"@type": "Question",
"name": "Quels tests révèlent des anomalies des chromatides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses cytogénétiques, comme le caryotype, peuvent détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Les chromatides peuvent-elles être analysées par PCR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut être utilisée pour analyser des segments spécifiques des chromatides."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'immunofluorescence dans l'étude des chromatides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunofluorescence permet de visualiser des protéines spécifiques sur les chromatides."
}
},
{
"@type": "Question",
"name": "Peut-on observer les chromatides en microscopie électronique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la microscopie électronique offre une résolution élevée pour observer les chromatides."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent des anomalies chromosomiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies chromosomiques peuvent entraîner des malformations congénitales ou des troubles du développement."
}
},
{
"@type": "Question",
"name": "Les anomalies des chromatides causent-elles des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent être liées à des maladies comme le syndrome de Down."
}
},
{
"@type": "Question",
"name": "Comment les anomalies des chromatides affectent-elles la santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des cancers ou des troubles génétiques héréditaires."
}
},
{
"@type": "Question",
"name": "Les symptômes des troubles chromosomiques sont-ils visibles à la naissance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent être visibles à la naissance, comme des traits faciaux caractéristiques."
}
},
{
"@type": "Question",
"name": "Les troubles des chromatides peuvent-ils affecter la fertilité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies chromosomiques peuvent entraîner des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies chromosomiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être évitées par des conseils génétiques et un suivi prénatal."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention des anomalies chromosomiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en acide folique peut réduire le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à prévenir des anomalies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques permettent d'identifier les risques d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "La vaccination peut-elle prévenir des anomalies chromosomiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui pourraient affecter le développement fœtal."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier aide-t-il à prévenir les anomalies chromosomiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier peut aider à détecter et gérer les risques d'anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies chromosomiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements varient selon la condition, incluant thérapies géniques et interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle utilisée pour traiter des anomalies des chromatides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie peut être utilisée pour traiter certains cancers liés à des anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils disponibles pour le syndrome de Turner ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements hormonaux et des interventions médicales peuvent aider les patients."
}
},
{
"@type": "Question",
"name": "Peut-on corriger les anomalies chromosomiques par chirurgie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être corrigées par chirurgie, selon leur nature et gravité."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles efficaces contre les anomalies chromosomiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques montrent un potentiel prometteur pour certaines anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'anomalies chromosomiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles du développement, des malformations et des cancers."
}
},
{
"@type": "Question",
"name": "Les anomalies des chromatides peuvent-elles entraîner des complications à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des complications chroniques et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment les anomalies chromosomiques affectent-elles la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des troubles mentaux ou des difficultés d'adaptation sociale."
}
},
{
"@type": "Question",
"name": "Les complications des anomalies chromosomiques sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup ne sont pas réversibles."
}
},
{
"@type": "Question",
"name": "Les anomalies chromosomiques augmentent-elles le risque de maladies auto-immunes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies chromosomiques peuvent être associées à un risque accru de maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge maternel avancé, des antécédents familiaux et certaines expositions environnementales."
}
},
{
"@type": "Question",
"name": "Les infections pendant la grossesse augmentent-elles les risques chromosomiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections comme la rubéole peuvent augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "L'exposition aux radiations influence-t-elle les anomalies chromosomiques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux radiations peut augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Le tabagisme maternel est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme pendant la grossesse est associé à un risque accru d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les facteurs génétiques jouent-ils un rôle dans les anomalies chromosomiques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations génétiques héréditaires peuvent augmenter le risque d'anomalies chromosomiques."
}
}
]
}
]
}
This case and commentary canvasses clinical, ethical, and public health considerations about integrated infection control and sustainability efforts of biocontainment units (BCUs). BCUs protect the pu...
Personal protective equipment (PPE) and infection prevention and control (IPC) measures are crucial to preventing the spread of coronavirus disease 2019 (COVID-19). This study used a scoping review to...
To describe existing, recent literature on PPE and IPC measures used in early intervention through a scoping review (steps 1-5) and to consult local clinicians to investigate how SLTs who provide ECI ...
A scoping review was performed which followed the PRISMA-ScR framework. Because of limited literature on PPE and IPC measures used by SLTs in providing ECI, the inclusion criteria were adjusted to inc...
Fourteen articles were included in the study. The scoping review of existing literature identified challenges to implementing IPC measures, namely the care and behaviour of young children, infrastruct...
This study identified challenges and recommendations of SLTs who use PPE and IPC measures whilst providing ECI. Understanding these challenges can benefit ECI services and future research efforts focu...
Infection prevention and control (IPC) programs in the Middle Eastern and North African (MENA) countries are evolving. The objective was to characterize IPC personnel and programs in MENA countries, w...
A cross-sectional online survey was conducted in 2019 among IPC members of the Arab Countries Infection Control Network (AcicN). The survey focused on three domains; demographic and professional chara...
A total of 269 participants aged 39.9 ± 8.4 years were included in the study. Majority of the participants were females (67.7%), nurses (63.7%), and of Middle-Eastern origin (57.3%). 32.2% of the part...
MENA countries had generally satisfactory IPC programs and to a lesser extent staffing, with considerable variability between countries with different resources....
Hand hygiene (HH) is the most effective way to curb the spread of healthcare-associated infections. Nonetheless, healthcare personnel encounter difficulties in adhering to WHO HH recommendations. This...
The purpose of our study was to compare the complication rate and the outcomes of custom-made spacers (C-spacers) and prefabricated articular spacers (P-spacers) in the treatment of periprosthetic inf...
In this retrospective study, 78 patients (44 females, 34 males; mean age: 68.5±9.48 years; range, 47 to 82 years) with articular spacers implanted in our institution were analyzed between January 2009...
There were 29 revised spacers; 18 of them were C-spacers and 11 were P-spacers (p=0.0383). A total of 16 dislocations were recorded, of which six were dislocations of C-spacers, and 10 were dislocatio...
Custom-made spacers were shown to have lower mechanical complication rates than prefabricated ones but more infection complications. Prefabricated spacers had more dislocations and fewer breakages. Cu...
To limit an infectious outbreak, the public must be informed about the infection risk and be motivated to comply with infection control measures. Perceiving a situation as threatening and seeing benef...
Private sector facilities in the United States have experienced a resurgence of Methicillin-resistant Staphylococcus aureus (MRSA) hospital-onset infections during the COVID-19 pandemic, which elimina...
National Strategic Plan to End tuberculosis (TB) in India 2020-2025 aims to prevent the emergence of TB in susceptible populations. Airborne infection control (AIC) practices in high-risk settings lik...
The objective is to assess the AIC practices (AICPs) in HFA in the Kollam district in Kerala, India....
A mixed method approach was used. the study was done in five HFA s in a southern district of Kerala to find AICPs. Using purposive sampling, in-depth interviews was conducted among inmates with recent...
Ventilation was inadequate in 25%-40% of HFA. Air change per hour and distance between beds were less. Very few inmates were aware of the need for proper ventilation and personal hygiene. Wearing mask...
There is a need to train the staff and inmates on AIC. Infrastructural improvements, like the use of partition screens in the short term and the creation of model airborne infection control HFA in the...
Infection prevention and control (IPC) in hospitals is key to safe patient care. There is currently no data regarding the implementation of IPC in hospitals in Indonesia. The aim of this study was to ...
A cross-sectional study was conducted from July to November 2021. Of all general hospitals in Indonesia, 20% (N = 475) were selected using stratified random sampling based on class (A, B, C and D; cla...
In total, 355 hospitals (74.7%) participated in this study. The overall median IPCAF score was 620.0 (535.0-687.5). The level of IPC was mostly assessed as advanced (56.9% of hospitals), followed by i...
The IPC level in the majority of Indonesian hospitals was assessed as advanced, but there was no even distribution over the country. The IPCAF in combination with interviews identified several priorit...
With advancements in technology, flexible bronchoscopes have become thinner in diameter and in need of more thorough reprocessing to prevent infection transmission than ever before. Many experienced b...
Bronchoscope reprocessing includes several distinct steps (precleaning, leak testing, manual cleaning, visual inspection, terminal reprocessing, rinsing and drying). Each step is comprehensive and nee...
Our article will focus on the most recent recommendations for effective reprocessing and disinfection of reusable bronchoscopes....